205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.12%
Revenue growth at 50-75% of MU's 25.12%. Martin Whitman would worry about competitiveness or product relevance.
16.17%
Gross profit growth at 75-90% of MU's 19.62%. Bill Ackman would demand operational improvements to match competitor gains.
10.22%
EBIT growth below 50% of MU's 71.58%. Michael Burry would suspect deeper competitive or cost structure issues.
12.17%
Operating income growth under 50% of MU's 71.58%. Michael Burry would be concerned about deeper cost or sales issues.
13.43%
Net income growth under 50% of MU's 36.82%. Michael Burry would suspect the firm is falling well behind a key competitor.
8.33%
EPS growth under 50% of MU's 36.92%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
8.70%
Diluted EPS growth under 50% of MU's 36.92%. Michael Burry would worry about an eroding competitive position or excessive dilution.
2.53%
Share count expansion well above MU's 0.08%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.38%
Diluted share count expanding well above MU's 0.08%. Michael Burry would fear significant dilution to existing owners' stakes.
0.49%
Dividend growth of 0.49% while MU is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
83.58%
OCF growth above 1.5x MU's 52.55%. David Dodd would confirm a clear edge in underlying cash generation.
152.78%
FCF growth above 1.5x MU's 71.16%. David Dodd would verify if the firm’s strategic investments yield superior returns.
12.26%
10Y revenue/share CAGR under 50% of MU's 608.73%. Michael Burry would suspect a lasting competitive disadvantage.
-16.56%
Negative 5Y CAGR while MU stands at 74.31%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
101.94%
3Y revenue/share CAGR above 1.5x MU's 22.91%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
153.21%
10Y OCF/share CAGR under 50% of MU's 475.83%. Michael Burry would worry about a persistent underperformance in cash creation.
94.23%
5Y OCF/share CAGR above 1.5x MU's 34.53%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
34.58%
3Y OCF/share CAGR under 50% of MU's 106.92%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
882.41%
Positive 10Y CAGR while MU is negative. John Neff might see a substantial advantage in bottom-line trajectory.
108.68%
Positive 5Y CAGR while MU is negative. John Neff might view this as a strong mid-term relative advantage.
1537.14%
Positive short-term CAGR while MU is negative. John Neff would see a clear advantage in near-term profit trajectory.
188.07%
Below 50% of MU's 461.78%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
162.02%
5Y equity/share CAGR at 75-90% of MU's 199.54%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
99.34%
3Y equity/share CAGR above 1.5x MU's 26.21%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
10.49%
Dividend/share CAGR of 10.49% while MU is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
27.18%
Stable or rising mid-term dividends while MU is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
-6.24%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-5.96%
Firm’s AR is declining while MU shows 23.35%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
18.73%
We show growth while MU is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
13.87%
Asset growth above 1.5x MU's 2.65%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
13.93%
BV/share growth above 1.5x MU's 1.00%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.91%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-3.71%
Our R&D shrinks while MU invests at 7.11%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
28.49%
SG&A growth well above MU's 7.41%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.